Grant Details
Grant Number: |
5R01CA246592-05 Interpret this number |
Primary Investigator: |
Toriola, Adetunji |
Organization: |
Washington University |
Project Title: |
Metabolite Profiles and Mammographic Density in Premenopausal Women |
Fiscal Year: |
2024 |
Abstract
ABSTRACT
In 2019, approximately 268,600 women in the US will be diagnosed with breast cancer, making it the leading
cause of cancer in women. About 25% of these cases occurred in premenopausal women. The annual
incidence of breast cancer among women under age 50 has been increasing slowly since the mid-1990s, in
contrast to what is observed in women aged over 50 years, where the incidence has remained stable over
time. This persistent increase in the incidence among younger women indicates that new approaches to
primary prevention in premenopausal women are needed. Mammographic breast density is one of the
strongest risk factors for breast cancer, especially in premenopausal women, where an estimated 39% of
breast cancer cases is attributable to having dense breasts. A decrease in breast density leads to a reduction
in breast cancer incidence. Nevertheless, the molecular basis of mammographic breast density and the
mechanisms through which dense breast increases breast cancer risk are poorly understood. A greater
understanding of these mechanisms is crucial, and will uncover new biological pathways and actionable
biomarkers that can be targeted to prevent breast cancer development. Metabolomics is a promising tool to
provide novel insights into disease etiology, biological mechanisms, and pathways. Metabolomics has,
however, not been applied to study mammographic breast density. Our pilot analyses show differences in
metabolite levels between women with fatty breasts compared to women with dense breasts. Building on these
novel findings, we will apply state-of-the art metabolomics platforms to 1) investigate the metabolome of
mammographic breast density in premenopausal women; 2) quantify the variation in mammographic breast
density explained by the metabolome; 3) determine whether the metabolome of mammographic breast density
predicts breast cancer development in premenopausal women. Our overarching hypothesis is that we will
leverage metabolomics to uncover the molecular mechanisms, biological pathways, as well as novel actionable
biomarkers that are associated with mammographic breast density in premenopausal women. Our study
population will consist of premenopausal women recruited during annual screening mammogram at the Joanne
Knight Breast Health Center at the Washington University School of Medicine, St. Louis, MO. Mammographic
breast density is quantitatively assessed using Volpara. Fasting blood samples are collected on the same day
the women have their mammograms. The women also complete a questionnaire with detailed information on
breast cancer risk factors and determinants of mammographic density. In conclusion, we will build on our
exciting preliminary data to uncover novel, actionable biomarkers associated with mammographic breast
density, and also breast cancer development in premenopausal women. These biomarkers could be targeted
in breast cancer prevention in future studies.
Publications
Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.
Authors: Singh R.K.
, Getz K.R.
, Kyeyune J.K.
, Jeon M.S.
, Luo C.
, Luo J.
, Toriola A.T.
.
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-08-01 00:00:00.0; 33(8), p. 1126-1128.
PMID: 38700429
Related Citations
How does weight gain since the age of 18 years affect breast cancer risk in later life? A meta-analysis.
Authors: Han Y.
, Otegbeye E.E.
, Stoll C.
, Hardi A.
, Colditz G.A.
, Toriola A.T.
.
Source: Breast Cancer Research : Bcr, 2024-03-07 00:00:00.0; 26(1), p. 39.
EPub date: 2024-03-07 00:00:00.0.
PMID: 38454466
Related Citations
Associations of Vitamins and Related Cofactor Metabolites with Mammographic Breast Density in Premenopausal Women.
Authors: Matthew K.A.
, Getz K.R.
, Jeon M.S.
, Luo C.
, Luo J.
, Toriola A.T.
.
Source: The Journal Of Nutrition, 2024 Feb; 154(2), p. 424-434.
EPub date: 2023-12-18 00:00:00.0.
PMID: 38122846
Related Citations
Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
Authors: Xu S.
, Murtagh S.
, Han Y.
, Wan F.
, Toriola A.T.
.
Source: Jama Network Open, 2024-01-02 00:00:00.0; 7(1), p. e2353331.
EPub date: 2024-01-02 00:00:00.0.
PMID: 38277147
Related Citations
Lipidome of mammographic breast density in premenopausal women.
Authors: Getz K.R.
, Jeon M.S.
, Luo C.
, Luo J.
, Toriola A.T.
.
Source: Breast Cancer Research : Bcr, 2023-10-09 00:00:00.0; 25(1), p. 121.
EPub date: 2023-10-09 00:00:00.0.
PMID: 37814330
Related Citations
Breastfeeding and Mammographic Breast Density: A Cross-sectional Study.
Authors: Getz K.R.
, Adedokun B.
, Xu S.
, Toriola A.T.
.
Source: Cancer Prevention Research (philadelphia, Pa.), 2023-06-01 00:00:00.0; 16(6), p. 353-361.
PMID: 36930943
Related Citations
Plasma Growth Factor Gene Expression and Mammographic Breast Density in Postmenopausal Women.
Authors: Akinjiyan F.A.
, Adams A.
, Xu S.
, Wang M.
, Toriola A.T.
.
Source: Cancer Prevention Research (philadelphia, Pa.), 2022-06-02 00:00:00.0; 15(6), p. 391-398.
PMID: 35288741
Related Citations
Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.
Authors: Mintz R.
, Wang M.
, Xu S.
, Colditz G.A.
, Markovic C.
, Toriola A.T.
.
Source: Breast Cancer Research : Bcr, 2022-04-14 00:00:00.0; 24(1), p. 28.
EPub date: 2022-04-14 00:00:00.0.
PMID: 35422057
Related Citations
Changes in adiposity over the life course and gene expression in postmenopausal women.
Authors: Han Y.
, Colditz G.A.
, Toriola A.T.
.
Source: Cancer Medicine, 2022-03-19 00:00:00.0; , .
EPub date: 2022-03-19 00:00:00.0.
PMID: 35304837
Related Citations
Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women.
Authors: Han Y.
, Moore J.X.
, Colditz G.A.
, Toriola A.T.
.
Source: Jama Network Open, 2022-02-01 00:00:00.0; 5(2), p. e2148983.
EPub date: 2022-02-01 00:00:00.0.
PMID: 35175341
Related Citations
Coffee, Tea, and Mammographic Breast Density in Premenopausal Women.
Authors: Odama A.M.
, Otti V.
, Xu S.
, Adebayo O.
, Toriola A.T.
.
Source: Nutrients, 2021-10-28 00:00:00.0; 13(11), .
EPub date: 2021-10-28 00:00:00.0.
PMID: 34836118
Related Citations
Medication use and mammographic breast density.
Authors: Han Y.
, Lee C.T.
, Xu S.
, Mi X.
, Phillip C.R.
, Salazar A.S.
, Rakhmankulova M.
, Toriola A.T.
.
Source: Breast Cancer Research And Treatment, 2021 Sep; 189(2), p. 585-592.
EPub date: 2021-07-01 00:00:00.0.
PMID: 34196899
Related Citations
Reply to Hopper, Nguyen, and Li.
Authors: Salazar A.S.
, Toriola A.T.
.
Source: Jnci Cancer Spectrum, 2021 Aug; 5(4), p. pkab052.
EPub date: 2021-06-14 00:00:00.0.
PMID: 34377933
Related Citations
Refining the Focus on Early Life and Adolescent Pathways to Prevent Breast Cancer.
Authors: Colditz G.A.
, Toriola A.T.
.
Source: Journal Of The National Cancer Institute, 2021-06-01 00:00:00.0; 113(6), p. 658-659.
PMID: 33136152
Related Citations
Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.
Authors: Salazar A.S.
, Rakhmankulova M.
, Simon L.E.
, Toriola A.T.
.
Source: Jnci Cancer Spectrum, 2021 Feb; 5(1), p. pkaa125.
EPub date: 2021-01-22 00:00:00.0.
PMID: 33554041
Related Citations
Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?
Authors: Akinjiyan F.A.
, Han Y.
, Luo J.
, Toriola A.T.
.
Source: Discover. Oncology, 2021; 12(1), p. 47.
EPub date: 2021-11-03 00:00:00.0.
PMID: 34790961
Related Citations
Determinants of Mammographic Breast Density by Race Among a Large Screening Population.
Authors: Moore J.X.
, Han Y.
, Appleton C.
, Colditz G.
, Toriola A.T.
.
Source: Jnci Cancer Spectrum, 2020 Apr; 4(2), p. pkaa010.
EPub date: 2020-02-26 00:00:00.0.
PMID: 32373777
Related Citations